First Time Loading...

Co-Diagnostics Inc
NASDAQ:CODX

Watchlist Manager
Co-Diagnostics Inc Logo
Co-Diagnostics Inc
NASDAQ:CODX
Watchlist
Price: 1.21 USD 0.83% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

CODX Price Targets Summary
Co-Diagnostics Inc

Wall Street analysts forecast CODX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CODX is 2.55 USD with a low forecast of 2.53 USD and a high forecast of 2.63 USD.

CODX Lowest Forecast
Wall Street Target
2.53 USD
109% Upside
CODX Average Forecast
Wall Street Target
2.55 USD
111% Upside
CODX Highest Forecast
Wall Street Target
2.63 USD
117% Upside
Lowest
Price Target
2.53 USD
109% Upside
Average
Price Target
2.55 USD
111% Upside
Highest
Price Target
2.63 USD
117% Upside
Co-Diagnostics Inc Competitors:
Price Targets
DXCM
Dexcom Inc
22% Upside
SRT
Sartorius AG
60% Upside
600055
Beijing Wandong Medical Technology Co Ltd
5% Downside
GKOS
Glaukos Corp
2% Upside
DXCM
Dexcom Inc
22% Upside
SRT
Sartorius AG
60% Upside
600055
Beijing Wandong Medical Technology Co Ltd
5% Downside
GKOS
Glaukos Corp
2% Upside
LIVN
LivaNova PLC
7% Upside
SYK
Stryker Corp
16% Upside
PEN
Penumbra Inc
36% Upside
BSX
Boston Scientific Corp
14% Upside

Revenue
Forecast

Revenue Estimate
Co-Diagnostics Inc

For the last 8 years the compound annual growth rate for Co-Diagnostics Inc's revenue is 126%. The projected CAGR for the next 1 year is -13%.

126%
Past Growth
-13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Co-Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Co-Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
CODX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CODX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CODX stock valuation using valuation multiples.
Wall Street Estimates
CODX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CODX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CODX's stock price target?
Price Target
2.55 USD

According to Wall Street analysts, the average 1-year price target for CODX is 2.55 USD with a low forecast of 2.53 USD and a high forecast of 2.63 USD.

What is Co-Diagnostics Inc's Revenue forecast?
Projected CAGR
-13%

For the last 8 years the compound annual growth rate for Co-Diagnostics Inc's revenue is 126%. The projected CAGR for the next 1 year is -13%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.